Supplementary Figure 4 from Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma
Key Points
Key points are not available for this paper at this time.
Abstract
This figure shows the single cell RNA sequencing analysis of EGFR high tumor subcluster in the humanized LUSC PDX model.
AIに質問
Like
Bookmark
Share
AIに質問
Like
Bookmark
Share
Supplementary Figure 4 from Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma | Synapse